Our finding that RARRES1 has tumor suppressive effects in TNBC regardless of subtype, differs from previous findings which suggested that RARRES1 is oncogenic in inflammatory breast cancer [16]. The gene discussed is RARRES1; the disease is inflammatory breast carcinoma.